Health Cor Management, L.P. Acadia Pharmaceuticals Inc Transaction History

Health Cor Management, L.P.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$19.4 - $27.42 $17.5 Million - $24.7 Million	-900,490 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$25.02 - $54.99 $22.5 Million - $49.5 Million	900,490 New	900,490 $23.2 Million
Q3 2020 Nov 16, 2020	SELL	$36.42 - $57.0 $37.3 Million - $58.4 Million	-1,025,000 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$39.26 - $52.73 $47.3 Million - $63.6 Million	-1,205,474 Reduced 54.05%	1,025,000 $49.7 Million
Q1 2020 May 15, 2020	BUY	$31.65 - $46.87 $70.6 Million - $105 Million	2,230,474 New	2,230,474 $94.2 Million
Q3 2019 Nov 14, 2019	SELL	$22.22 - $44.01 $2.65 Million - $5.26 Million	-119,484 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$23.32 - $28.12 $2.79 Million - $3.36 Million	119,484 New	119,484 $3.19 Million
Q2 2018 Aug 14, 2018	SELL	$15.07 - $22.34 $20.8 Million - $30.8 Million	-1,378,000 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$22.47 - $32.33 $31 Million - $44.6 Million	1,378,000 New	1,378,000 $31 Million

280

156M

901K

314K

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.62B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

Get notified when there are updates to the investment portfolio of Health Cor Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Health Cor Management, L.P. with notifications on news.